Contact Us  
Home  |  About Us   |  Investor Services   
Equity
   Equity Analysis
  News Analysis
  Corporate Action
  Other Market
  Company Profile
Derivatives
IPO
BSE Company News
Gland Pharma Ltd.
BSE Code 543245
ISIN Demat INE068V01023
Book Value (Rs) 526.70
NSE Code GLAND
Dividend Yield % 0.00
Market Cap(Rs Mn) 295120.08
TTM PE(x) 36.84
TTM EPS(Rs) 48.64
Face Value (Rs) 1  
Industry : Pharmaceuticals & Drugs
  
08-May-2024 Gland Pharma gains on getting USFDA’s approval fo...
07-May-2024 Gland Pharma gets USFDA’s approval for Edaravone ...
07-May-2024 Gland Pharma gets USFDA’s approval for Plerixafor...
07-May-2024 Gland Pharma gains on getting USFDA’s approval fo...
29-Apr-2024 Gland Pharma gets USFDA’s approval for Cetrorelix...
29-Apr-2024 Gland Pharma informs about press release
10-Apr-2024 Clarification sought from Gland Pharma Ltd
08-Apr-2024 Gland Pharma gets USFDA’s approval for Eribulin M...
08-Apr-2024 Gland Pharma shines on getting USFDA’s approval f...
21-Feb-2024 Gland Pharma informs about earnings call transcri...
18-Jan-2024 Gland Pharma informs about analyst meet
07-Dec-2023 Gland Pharma informs about analyst meet
24-Nov-2023 Gland Pharma gets EIR for Pashamylaram Facility
24-Nov-2023 Gland Pharma informs about disclosure
24-Nov-2023 Gland Pharma surges on getting EIR for Pashamylar...
Page 1 of 2
Prev || Next